These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21128892)

  • 1. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2010; 16(34):3939-847. PubMed ID: 21128892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention of type 2 diabetes: what is the evidence?
    Chiasson JL; Brindisi MC; Rabasa-Lhoret R
    Minerva Endocrinol; 2005 Sep; 30(3):179-91. PubMed ID: 16208307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and surgical intervention for the prevention of diabetes.
    Chiasson JL
    Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():31-42. PubMed ID: 16820729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of type 2 diabetes.
    Crandall JP; Knowler WC; Kahn SE; Marrero D; Florez JC; Bray GA; Haffner SM; Hoskin M; Nathan DM;
    Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):382-93. PubMed ID: 18493227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of β-cell function: the key to diabetes prevention.
    DeFronzo RA; Abdul-Ghani MA
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the pharmacotherapy options for treating prediabetes?
    Daniele G; Abdul-Ghani M; DeFronzo RA
    Expert Opin Pharmacother; 2014 Oct; 15(14):2003-18. PubMed ID: 25139488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
    Smith-Marsh D
    Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Into the future: prevention of diabetes.
    Bogaert YE; Schrier RW
    Contrib Nephrol; 2011; 170():256-263. PubMed ID: 21659778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of type 2 diabetes mellitus].
    Lyra R; Oliveira M; Lins D; Cavalcanti N
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):239-49. PubMed ID: 16767290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can type 2 diabetes mellitus be considered preventable?
    Jermendy G
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S73-81. PubMed ID: 15955380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of type 2 diabetes.
    Laakso M
    Curr Mol Med; 2005 May; 5(3):365-74. PubMed ID: 15892655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures.
    Liberopoulos EN; Tsouli S; Mikhailidis DP; Elisaf MS
    Curr Drug Targets; 2006 Feb; 7(2):211-28. PubMed ID: 16475962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired glucose tolerance: is there a case for pharmacologic intervention?
    Costa A; Conget I; Gomis R
    Treat Endocrinol; 2002; 1(4):205-10. PubMed ID: 15799213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Type 2 diabetes: fact or fiction?
    Chiasson JL
    Expert Opin Pharmacother; 2007 Dec; 8(18):3147-58. PubMed ID: 18035959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.
    Zinman B; Harris SB; Gerstein HC; Young TK; Raboud JM; Neuman J; Hanley AJ
    Diabetes Obes Metab; 2006 Sep; 8(5):531-7. PubMed ID: 16918588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.
    Stevens JW; Khunti K; Harvey R; Johnson M; Preston L; Woods HB; Davies M; Goyder E
    Diabetes Res Clin Pract; 2015 Mar; 107(3):320-31. PubMed ID: 25638454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.